MedPath

石家庄凯达生物工程有限公司

Ownership
-
Established
1991-09-17
Employees
-
Market Cap
-
Website
kaidashengwu.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

35

NMPA:35

Drug Approvals

Piracetam Injection

Product Name
吡拉西坦注射液
Approval Number
国药准字H20253688
Approval Date
Mar 25, 2025
NMPA

Piracetam Injection

Product Name
吡拉西坦注射液
Approval Number
国药准字H20253689
Approval Date
Mar 25, 2025
NMPA

Piracetam Injection

Product Name
吡拉西坦注射液
Approval Number
国药准字H20253690
Approval Date
Mar 25, 2025
NMPA

Diagnostic kit for Antibody to Treponema Pallidum (ELISA)

Product Name
梅毒螺旋体抗体诊断试剂盒(酶联免疫法)
Approval Number
国药准字S20083004
Approval Date
Jul 21, 2023
NMPA

Diagnostic kit for Antibody to Hepatitis C Virus(enzyme linked immunosurbent assay)

Product Name
丙型肝炎病毒抗体诊断试剂盒(酶联免疫法)
Approval Number
国药准字S20073015
Approval Date
Jul 21, 2023
NMPA

Ifosfamide for Injection

Product Name
注射用异环磷酰胺
Approval Number
国药准字H20064840
Approval Date
Jul 21, 2023
NMPA

Paclitaxel Injection

Product Name
紫杉醇注射液
Approval Number
国药准字H20067186
Approval Date
Jul 21, 2023
NMPA

Fasudil Hydrochloride Injection

Product Name
盐酸法舒地尔注射液
Approval Number
国药准字H20133151
Approval Date
Feb 15, 2023
NMPA

Magnesium Sulfate Injection

Product Name
硫酸镁注射液
Approval Number
国药准字H20223949
Approval Date
Dec 30, 2022
NMPA

Magnesium Sulfate Injection

Product Name
硫酸镁注射液
Approval Number
国药准字H20223948
Approval Date
Dec 30, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.